CASE Op-Ed – RealClear Markets: Nancy Pelosi’s Price Fixing Scheme Threatens Drug Innovation
Gerard Scimeca – Chairman, CASE January 7, 2020 Addressing sky-high healthcare costs is a pressing need in our country,...
Hospitals Support Transparency, Except When They Have To Be Transparent
August 16, 2019 Last month, The Centers for Medicare and Medicaid Services released a new proposal which will increase price...
Importing Prescription Drugs: Unsafe and Unwanted
Yesterday, the U.S. Department of Health and Human Services released a proposal, outlining two pathways to allow for the importation...
CASE Op-Ed – RealClear Energy: Always Evolving Coal Technologies Key to Trump’s Climate Plan
Matthew Kandrach – President, CASE June 26, 2019 As the United States enters a long era of reducing carbon emissions,...
CASE Op-Ed – RealClear Health: Socialist Price Schemes Will Be Harmful to Patients
Matthew Kandrach – President, CASE June 3, 2019 – https://bit.ly/2KoGoEr A recent study published in Health Affairs reached a controversial conclusion, that...
CASE Op-ed, InsideSources: America Deserves Quality Infrastructure
Matthew Kandrach – President CASE March 4, 2019 – https://bit.ly/2EAZi6S The Senate Commerce Committee in February took up how multiple...
The Six Protected Classes Are Protected For A Reason
We’ve been vocal about how the Trump Administration has championed patients in their efforts to lower the cost of...
CASE Op-Ed, InsideSources: Let’s Not Pollute our Waterways with Unnecessary Federal Regulation
Matthew Kandrach – President, CASE December 21, 2018 – https://bit.ly/2CtZdlp Is it possible to have cleaner waterways across the country and,...
The Problem With Price Caps: Why CMS Should Rethink Its Part B Proposal
This week, we submitted comments to Health and Human Services (HHS) Secretary Alex Azar, urging him to reevaluate and abandon...
Government Plan on Drug Pricing Ads Won’t Help Consumers
Almost everyone agrees patients should know what their medicines cost them, and that drug pricing should be made more clear...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/